[go: up one dir, main page]

DK141757B - Fremgangsmåde til fremstilling af et immunostimulerende glycopeptid fra Corynebacterium parvum. - Google Patents

Fremgangsmåde til fremstilling af et immunostimulerende glycopeptid fra Corynebacterium parvum. Download PDF

Info

Publication number
DK141757B
DK141757B DK96174AA DK96174A DK141757B DK 141757 B DK141757 B DK 141757B DK 96174A A DK96174A A DK 96174AA DK 96174 A DK96174 A DK 96174A DK 141757 B DK141757 B DK 141757B
Authority
DK
Denmark
Prior art keywords
glycopeptide
immunostimulatory
cells
mice
max
Prior art date
Application number
DK96174AA
Other languages
Danish (da)
English (en)
Other versions
DK141757C (ja
Inventor
Christopher Adlam
David Eric Reid
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK141757B publication Critical patent/DK141757B/da
Application granted granted Critical
Publication of DK141757C publication Critical patent/DK141757C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96174AA 1973-02-23 1974-02-22 Fremgangsmåde til fremstilling af et immunostimulerende glycopeptid fra Corynebacterium parvum. DK141757B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB914973A GB1476422A (en) 1973-02-23 1973-02-23 Biological extracts
GB914973 1973-02-23

Publications (2)

Publication Number Publication Date
DK141757B true DK141757B (da) 1980-06-09
DK141757C DK141757C (ja) 1980-10-27

Family

ID=9866339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96174AA DK141757B (da) 1973-02-23 1974-02-22 Fremgangsmåde til fremstilling af et immunostimulerende glycopeptid fra Corynebacterium parvum.

Country Status (12)

Country Link
JP (1) JPS5063196A (ja)
AU (1) AU6591074A (ja)
BE (1) BE811491A (ja)
DE (1) DE2408724A1 (ja)
DK (1) DK141757B (ja)
FR (1) FR2218888B1 (ja)
GB (1) GB1476422A (ja)
HU (1) HU173676B (ja)
IE (1) IE39332B1 (ja)
IL (1) IL44267A (ja)
NL (1) NL7402455A (ja)
ZA (1) ZA741189B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2410476B1 (fr) * 1977-11-30 1980-08-22 Inst Nat Sante Rech Med Application des peptidoglycanes extraits de bacteries, en particulier des bacillus a titre de medicaments, notamment stimulant l'immunite antitumorale
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
FR2502496A2 (fr) * 1981-03-30 1982-10-01 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation
FR2480604A1 (fr) * 1980-04-22 1981-10-23 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon et leur procede de preparation
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
US4871488A (en) * 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
DK3049430T3 (en) 2014-07-16 2019-04-08 Depofarma S P A CELL WALL FRACTION OF PROPIONIBACTERIUM GRANULOSUM WITH IMMUNO MODULATING EFFECT

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450815A (en) * 1964-04-24 1969-06-17 Princeton Lab Inc Method of stimulating a host defense mechanism with an actinovaccine
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections

Also Published As

Publication number Publication date
BE811491A (fr) 1974-08-22
IE39332B1 (en) 1978-09-13
NL7402455A (ja) 1974-08-27
FR2218888B1 (ja) 1976-12-03
DK141757C (ja) 1980-10-27
ZA741189B (en) 1975-09-24
GB1476422A (en) 1977-06-16
IL44267A (en) 1978-07-31
FR2218888A1 (ja) 1974-09-20
DE2408724A1 (de) 1974-09-05
IE39332L (en) 1974-08-23
AU6591074A (en) 1975-08-28
HU173676B (hu) 1979-07-28
IL44267A0 (en) 1974-05-16
JPS5063196A (ja) 1975-05-29

Similar Documents

Publication Publication Date Title
EP0008969B1 (en) Vaccine and method of making
Garner et al. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
Hollingdale et al. The antigens of Mycoplasma hominis
FI59024B (fi) Foerfarande foer framstaellning och rening av en antigen till c-gruppen hoerande meningokockpolysackarid som har hoeg molekylvikt och aer aktiv mot av c-gruppens meningokocker orsakad meningit
US4010257A (en) Biological extracts
US4152423A (en) Immunological agents
DK141757B (da) Fremgangsmåde til fremstilling af et immunostimulerende glycopeptid fra Corynebacterium parvum.
US4501693A (en) Method of preparing immunostimulant proteoglycans which induce production of interferon, proteoglycans obtained and pharmaceutical compositions containing them
Costea et al. Inhibition of cold agglutinins (anti-I) by M. pneumoniae antigens
Haughton EXTRACTION OF H-2 ANTIGEN FROM MOUSE: TUMOUR CELLS
US7090857B2 (en) Antigenic preparations
US4220638A (en) Antigenic complex from N. Gonorrhoeae
KR100197446B1 (ko) 펠리누스 린테우스로부터 분리된 항암 면역활성 다당류 및 이의 제조 방법
AU655425B2 (en) Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
US4069314A (en) Glycopeptide extract
Hammond Isolation and serological characterization of a cell wall antigen of Rothia dentocariosa
Kurbatova et al. The use of biotinylated oligosaccharides related to fragments of capsular polysaccharides from Streptococcus pneumoniae serotypes 3 and 14 as a tool for assessment of the level of vaccine-induced antibody response to neoglycoconjugates
US4374827A (en) Water soluble extract from nonpathogenic aerobic corynebacteria
EP0037441B1 (en) Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein
US4288557A (en) Antigenic complex from N. gonorrhoeae
US5869645A (en) Method for isolating high molecular weight antineoplastic glycans using urea
RU2023445C1 (ru) Способ получения иммуномодулятора
EP0615758B1 (en) Anti-tumor vaccines
Kligler et al. The antigenic composition of Trypanosoma evansi
Davies H‐2 Histocompatibility Antigens of the Mouse